国新健康
(000503)
| 流通市值：74.03亿 | | | 总市值：74.03亿 |
| 流通股本：9.79亿 | | | 总股本：9.79亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 101,543,897.09 | 50,520,618.6 | 350,444,166.57 | 170,401,734.11 |
| 营业总成本 | 206,596,943.51 | 103,573,911.28 | 502,143,782.43 | 323,277,664.25 |
| 其他经营收益 | | | | |
| 营业利润 | -102,059,407.92 | -48,604,433.73 | -402,595,517.97 | -137,738,063.51 |
| 利润总额 | -102,070,304.7 | -48,632,474.93 | -403,919,647.23 | -137,994,161.75 |
| 净利润 | -102,268,992.68 | -48,632,474.93 | -403,993,560.02 | -138,429,304.65 |
| 每股收益 | | | | |
| 其他综合收益 | -132,540.76 | -67,439.93 | 6,255,694.96 | -152,869.38 |
| 综合收益总额 | -102,401,533.44 | -48,699,914.86 | -397,737,865.06 | -138,582,174.03 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,119,436,239.08 | 1,196,326,985.58 | 1,244,484,551.99 | 1,484,104,556.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 548,146,803.38 | 552,219,600.65 | 555,252,842.98 | 527,736,886.29 |
| 资产总计 | 1,667,583,042.46 | 1,748,546,586.23 | 1,799,737,394.97 | 2,011,841,442.6 |
| 流动负债: | | | | |
| 流动负债合计 | 366,273,029.51 | 610,347,632.2 | 612,874,611.55 | 554,211,269.6 |
| 非流动负债: | | | | |
| 非流动负债合计 | 183,645,275.95 | 179,030,550.75 | 178,994,465.28 | 190,606,163.83 |
| 负债合计 | 549,918,305.46 | 789,378,182.95 | 791,869,076.83 | 744,817,433.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,117,664,737 | 959,168,403.28 | 1,007,868,318.14 | 1,267,024,009.17 |
| 股东权益合计 | 1,117,664,737 | 959,168,403.28 | 1,007,868,318.14 | 1,267,024,009.17 |
| 负债和股东权益合计 | 1,667,583,042.46 | 1,748,546,586.23 | 1,799,737,394.97 | 2,011,841,442.6 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 107,284,376.94 | 40,838,270.24 | 409,308,176 | 203,225,240.08 |
| 经营活动现金流出小计 | 243,918,346.25 | 107,900,523.47 | 490,967,987.41 | 385,918,148.26 |
| 经营活动产生的现金流量净额 | -136,633,969.31 | -67,062,253.23 | -81,659,811.41 | -182,692,908.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 546,076,598.7 | 346,171,946.4 | 488,433,093.32 | 284,663,868.63 |
| 投资活动现金流出小计 | 556,657,630.94 | 545,933,555.75 | 398,319,238.9 | 377,854,768.29 |
| 投资活动产生的现金流量净额 | -10,581,032.24 | -199,761,609.35 | 90,113,854.42 | -93,190,899.66 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 185,000,000 | 50,000,000 | 283,249,265.86 | 283,249,265.86 |
| 筹资活动现金流出小计 | 214,885,628.19 | 36,047,556.31 | 182,669,926.44 | 140,627,952.79 |
| 筹资活动产生的现金流量净额 | -29,885,628.19 | 13,952,443.69 | 100,579,339.42 | 142,621,313.07 |
| 汇率变动对现金及现金等价物的影响 | -180,261.11 | -114,342.65 | -379,212.49 | -192,411.68 |
| 现金及现金等价物净增加额 | -177,280,890.85 | -252,985,761.54 | 108,654,169.94 | -133,454,906.45 |
| 期末现金及现金等价物余额 | 368,754,356.49 | 293,042,814.45 | 546,035,247.34 | 303,897,129.54 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -177,280,890.85 | - | 108,654,169.94 | - |